Announced
Financials
Sources
Tags
Canada
Acquisition
Majority
Single Bidder
cannabinoid
Public
Cross Border
Merger
Pending
Biotechnology
Friendly
Synopsis
Global Cannabinoids, a bulk and wholesale B2B manufacturer and distributor of hemp-derived cannabinoids and finished products, is set to merge with EXMceuticals, an emerging bio-sciences company specializing in the production of unique cannabinoid formulations. GC will own c. 66% of EXM's issued and outstanding shares and existing EXM shareholders will hold c. 33% of EXM's issued and outstanding shares on a proforma basis. Financial terms were not disclosed. "The team at EXM shares the same vision for the future as we do. GC's commitment to quality, consistency and best in class pricing, combined with EXM's global reach, will allow for rapid expansion to customers in emerging markets. We are excited for the opportunities ahead," Kelly Ann Lewis-Bortman, GC's Chief Executive Officer.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.